Rett Syndrome Registry

NCT05432349 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2023-01-11

No results posted yet for this study

Summary

The Rett Syndrome Registry is a longitudinal observational study of individuals with MECP2 mutations and a diagnosis of Rett syndrome. Designed together with the IRSF Rett Syndrome Center of Excellence Network medical directors, this study collects data on the signs and symptoms of Rett syndrome as reported by the Rett syndrome experts and by the caregivers of individuals with Rett syndrome. This study will be used to develop consensus based guidelines for the care of your loved ones with Rett syndrome and to facilitate the development of better clinical trials and other aspects of the drug development path for Rett syndrome.

Conditions

  • Rett Syndrome
  • Rett Syndrome, Atypical
  • Genetic Disease
  • Genetic Diseases, X-Linked
  • Intellectual Disability
  • Neurobehavioral Manifestations
  • Neurologic Manifestations
  • Neurologic Disorder
  • Neurodevelopmental Disorders
  • Nervous System Diseases

Sponsors & Collaborators

  • Boston Children's Hospital

    collaborator OTHER
  • Children's Health UTSW

    collaborator UNKNOWN
  • Children's Hospital Colorado

    collaborator OTHER
  • Children's Hospital of Philadelphia

    collaborator OTHER
  • Gillette Children's Specialty Healthcare

    collaborator OTHER
  • Greenwood Genetic Center

    collaborator OTHER
  • Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

    collaborator OTHER
  • Montefiore Medical Center

    collaborator OTHER
  • Rush University

    collaborator OTHER
  • St. Louis Children's Hospital

    collaborator OTHER
  • Baylor College of Medicine

    collaborator OTHER
  • University of Alabama at Birmingham

    collaborator OTHER
  • UCSF Benioff Children's Hospital Oakland

    collaborator OTHER
  • Vanderbilt University Medical Center

    collaborator OTHER
  • Hive Networks

    collaborator UNKNOWN
  • International Rett Syndrome Foundation

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-02
Primary Completion
2027-07-31
Completion
2028-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05432349 on ClinicalTrials.gov